ClinicalTrials.gg

Hypersensitivity clinical trials

The registry lists 1,059 studies for Hypersensitivity across more than 10 countries. 152 are recruiting or about to start. 367 of them are mainly about Hypersensitivity (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-19. Counting its 31 narrower conditions too, such as Asthma: 10,106 studies, 1,470 open.

ClinicalTrials.gov finds 14,178 studies for Hypersensitivity. How that becomes 1,059 hereChecked on ClinicalTrials.gov . The studies here are updated every night.

This page counts the studies the registry files under Hypersensitivity, and those it files under no condition that list Hypersensitivitythemselves. Each study its search finds is placed by how the registry filed it and by the conditions it lists. Only this comparison waits for its turn: it is asked again about once a week, so between two checks the registry's number can run a little ahead of it. How condition pages count

  1. 14,178Found by its condition search · See all 14,178 hereIt reads the conditions a study lists and their synonyms, and also titles and keywords.
  2. −8,528Filed under a narrower condition, counted on its own pageAsthma 4,290 · Dermatitis, Atopic 1,448 · Rhinitis, Allergic 508 · Food Hypersensitivity 262 · Rhinitis, Allergic, Seasonal 257 · Sarcoidosis 241 · 25 more
  3. −393List Hypersensitivity as a condition, but the registry did not file them under itMost often written as “Dentin Hypersensitivity” (72), “Penicillin Allergy” (26), and “Dentine Hypersensitivity” (26). The registry filed 156 of them under no condition at all, and the others under other conditions only, most often Dentin Sensitivity (117) and Drug Hypersensitivity (35).
  4. −4,198Match it another way235 name it in the title, 70 in a keyword, and 3,893 by a synonym or other text the search reads.
  5. 1,059The count on this page

Get an email when these change. Save the Hypersensitivity studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Status

Completed
692
Status unknown
109
Recruiting
101
Terminated
56
Not yet recruiting
40
Active, not recruiting
27

Phase

Phase 2
159
Phase 3
119
Phase 1
99
Phase 4
51
Early Phase 1
8

Where

United States
302
France
107
Canada
86
Germany
81
United Kingdom
70
Spain
65

What is being tested here

Drugs under test in Hypersensitivity studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

Drug classes tested here Bronchodilators 3 open · Tyrosine kinase inhibitors (TKIs) 1 open · Antihistamines 27 · Corticosteroids 18

Coming up

47studies finish main data collection within a year5 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 101 Hypersensitivity studies recruiting now, 38 (38%) set no upper age limit and 51 (50%) stop at 75 or younger. 55 (54%) take children under 18. 4 (4%) are for women only and 0 (0%) for men only; 37 (37%) take healthy volunteers.

Recruiting studies that take each age, of 101
AgeWomenMen
1033 (33%)32 (32%)
1872 (71%)69 (68%)
3074 (73%)70 (69%)
4074 (73%)70 (69%)
5069 (68%)67 (66%)
6562 (61%)60 (59%)
7550 (50%)49 (49%)
8548 (48%)47 (47%)

Across all 1,059 studies, recruiting or not: 59% stop at 75 or younger and 52% at 65; 39% take children; 5% are for women only and 1% for men only; 36% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Hypersensitivity studies take

Of 42 phase 3 interventional studies under Hypersensitivity, half reached primary completion within 23 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 114 mo5–17 · 26 studies——
Phase 229 mo11–51 · 30 studies——
Phase 323 mo10–34 · 42 studies20 mo9–34 · 32 studies—
Interventional, no phase20 mo5–41 · 175 studies2 mo1–11 · 24 studies23 mo7–43 · 151 studies
Observational41 mo19–136 · 125 studies—45 mo19–203 · 102 studies

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 21, 2026.

Studies

Recruiting first, then most recently updated. Showing 50 of 1,059. Browse all 1,059 → or search them.